1. Home
  2. TENX vs PT Comparison

TENX vs PT Comparison

Compare TENX & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • PT
  • Stock Information
  • Founded
  • TENX 1967
  • PT 2012
  • Country
  • TENX United States
  • PT China
  • Employees
  • TENX N/A
  • PT N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • TENX Health Care
  • PT Technology
  • Exchange
  • TENX Nasdaq
  • PT Nasdaq
  • Market Cap
  • TENX 11.4M
  • PT 14.9M
  • IPO Year
  • TENX N/A
  • PT 2018
  • Fundamental
  • Price
  • TENX $3.34
  • PT $0.93
  • Analyst Decision
  • TENX Strong Buy
  • PT
  • Analyst Count
  • TENX 2
  • PT 0
  • Target Price
  • TENX $30.00
  • PT N/A
  • AVG Volume (30 Days)
  • TENX 29.8K
  • PT 32.3K
  • Earning Date
  • TENX 11-11-2024
  • PT 04-30-2024
  • Dividend Yield
  • TENX N/A
  • PT N/A
  • EPS Growth
  • TENX N/A
  • PT N/A
  • EPS
  • TENX N/A
  • PT N/A
  • Revenue
  • TENX N/A
  • PT $7,434,458.00
  • Revenue This Year
  • TENX N/A
  • PT N/A
  • Revenue Next Year
  • TENX N/A
  • PT N/A
  • P/E Ratio
  • TENX N/A
  • PT N/A
  • Revenue Growth
  • TENX N/A
  • PT N/A
  • 52 Week Low
  • TENX $2.77
  • PT $0.71
  • 52 Week High
  • TENX $61.20
  • PT $1.38
  • Technical
  • Relative Strength Index (RSI)
  • TENX 37.74
  • PT 39.94
  • Support Level
  • TENX $3.28
  • PT $0.76
  • Resistance Level
  • TENX $3.55
  • PT $1.12
  • Average True Range (ATR)
  • TENX 0.22
  • PT 0.09
  • MACD
  • TENX -0.03
  • PT -0.01
  • Stochastic Oscillator
  • TENX 8.96
  • PT 45.83

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

Share on Social Networks: